Hyperlipidaemia/ cholesterolaemia Flashcards
Compare the 2 types of causes of Hypercholesterolaemia
Familial Hypercholesterolaemia;
- Suspect if Total C>7.5 or PMH/ FHx of premature CHD
- May see tendon Xanthoma or Premature Arcus Senilis (<45)
- High CVD risk, need high intensity lipid-lowering treatment
2ndary Hypercholesterolaemia;
- Conditions or Drugs
List the 3 statin intensities and give examples
Low;
- Simvastatin 10mg
Medium;
- Simvastatin 20, 40mg
- Atorvastatin 10mg
High;
- Atorvastatin 20,40,80mg
State the normal Total Cholesterol, Non HDL-C, HDL-C
Total: <5mM
Non HDL-C: <4mM
HDL-C: >1 for men, >1.2 for women
List 3 statin-alternative drugs to treat Hypercholesterolaemia
- Fenofibrates
- Cholesterol absorption inhibitors
- NPC1L1 inhibitors
What is the target for lipid modification?
> 40% reduction in non HDL-C levels
What assessment and blood tests are needed before starting statin treatment?
Alcohol, Smoking, BMI, BP
Non-fasting lipid profile (Total cholesterol, HDL-C, non-HDL-C, TAGs)
LFTs, Renal function (eGFR)
HbA1c, Creatine Kinase
TSH, if Dyslipidaemia is present
Outline the follow-up of statin treatment
- Lipid profile: 3mths after starting treatment
- LFTs: 3mths AND 12mths after starting treatment
- Statin treatment: Review annually
- If unexplained symptoms: Check CK (Stop treatment if x5 of normal), Explore other causes
Who should be offered Lipid-lowering Primary Prevention based on their QRISK?
• People <85 with QRISK of 10% or more
• Type 1 diabetics; ◦ Aged >40 ◦ Have had diabetes for >10 yrs ◦ Have established Neuropathy ◦ Other CVD RFs
- People with CKD
- People with Familial Hypercholesterolaemia
Which pt groups don’t need formal risk assessment before starting lipid-lowering primary prevention?
(Already at CVD risk)
- Type 1 DM
- CKD
- Familial Hypercholesterolaemia